Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
European Journal of Haematology|July 1, 2024
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expressionPierre Allard, Laura Tagliaferri, Vivienn Weru, et al.BMC Cancer|June 20, 2018
MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κBDavid M Cordas Dos Santos, Juliane Eilers, Alfonso Sosa Vizcaino, et al.European Journal of Haematology|April 18, 2024
Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell diseaseMariane de Montalembert, Alan Anderson, Fernando F Costa, et al.Clinical Immunology (Orlando, Fla.)|December 6, 2016
Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC)Laura Tagliaferri, Joachim B Kunz, Margit Happich, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2006
Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literatureA P Oranje, A C A Devillers, B Kunz, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2016
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patientsA Wollenberg, A Oranje, M Deleuran, et al.Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.Allergy|March 19, 2011
Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in EuropeJ-F Stalder, S Barbarot, A Wollenberg, et al.Pageof 13